Trump Strikes Final Drug-Pricing Deal with Regeneron, Medical Marijuana Reclassified to Schedule III
President Trump finalized a drug-pricing agreement with Regeneron Pharmaceuticals, completing the last of 17 deals sought by the White House. Meanwhil...
